We are live on
!
Find out more
SGCIA
Smith Graham & Co Investment Advisors Portfolio holdings
AUM
$868M
1-Year Est. Return
24.69%
This Fund
S&P 500
This Quarter
Est. Return
+4.27%
1 Year Est. Return
+24.69%
3 Year Est. Return
+56.92%
5 Year Est. Return
+190.77%
10 Year Est. Return
+331.98%
AUM
$928M
AUM Growth
+$17.7M
(+1.9%)
Cap. Flow
-$5.25M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
13.34%
Holding
134
New
3
Increased
22
Reduced
107
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HIBB
Hibbett, Inc. Common Stock
HIBB
|
+$9.48M |
| 2 |
CARB
Carbonite Inc
CARB
|
+$5.32M |
| 3 |
Textron
TXT
|
+$4.07M |
| 4 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$3.38M |
| 5 |
CHS
Chicos FAS, Inc.
CHS
|
+$3.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EFII
Electronics for Imaging
EFII
|
+$8.7M |
| 2 |
TSS
Total System Services, Inc.
TSS
|
+$6.01M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$5.39M |
| 4 |
UCTT
Ultra Clean Holdings
UCTT
|
+$1.93M |
| 5 |
Deckers Outdoor
DECK
|
+$1.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.12% |
| 2 | Technology | 20.17% |
| 3 | Industrials | 18.32% |
| 4 | Consumer Discretionary | 16.82% |
| 5 | Healthcare | 8.36% |
Similar funds
SFG
FAAM
DGAM
LF
CCPV
ESCM
B
CWM
Smith Graham & Co Investment Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Smith Graham & Co Investment Advisors held 134 positions worth $928M, up 1.9% from $910M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Trading was light in Q2 2019: portfolio turnover was 3.7%. Smith Graham & Co Investment Advisors opened 3 new positions and exited 2, leaving the 134-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- Smith Graham & Co Investment Advisors's largest Q2 2019 buy was Hibbett, Inc. Common Stock: 451,416 shares worth $8.22M.
- Smith Graham & Co Investment Advisors added most to Eagle Pharmaceuticals, Inc. in Q2 2019, an estimated $3.38M increase.
- Smith Graham & Co Investment Advisors's biggest Q2 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $5.39M.
- Smith Graham & Co Investment Advisors fully exited Electronics for Imaging in Q2 2019, selling an estimated $8.7M.
- Smith Graham & Co Investment Advisors's ten largest holdings make up 13% of its $928M portfolio in Q2 2019.
- Smith Graham & Co Investment Advisors opened 3 new positions and closed 2 in Q2 2019.
- Smith Graham & Co Investment Advisors's portfolio value rose 1.9% quarter-over-quarter to $928M.
Based on Smith Graham & Co Investment Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.